Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.
about
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveThe regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genesPseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis.Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort StudyBacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre ExperienceCharacterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.Low-virulence Citrobacter species encode resistance to multiple antimicrobials.European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in LeukemiaDerivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance studyBloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.Incidence rate of fluoroquinolone-resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis.Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting.Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification.Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation.Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.Risk factors for mortality in patients with bloodstream infections during the pre-engraftment period after hematopoietic stem cell transplantationUmbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years.Current trends of infectious complications following hematopoietic stem cell transplantation in a single center.Role of interleukin-15 in umbilical cord blood transplantation.Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients.Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant RecipientsAntibiotic management of febrile neutropenia: current developments and future directions.Management of gram-positive bacterial infections in patients with cancer.Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.Escherichia coli: an important pathogen in patients with hematologic malignancies.Phenotypic detection and molecular characterization of beta-lactamase genes among Citrobacter species in a tertiary care hospital.Model systems for the study of Enterococcal colonization and infection.Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence?Incidence and risk factors of bacterial infections in children following autologous hematopoietic stem cell transplantation: Single-center experience from Jordan.Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.Oral status of patients submitted to autologous hematopoietic stem cell transplantation.Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
P2860
Q28388806-533B9790-C1E2-4163-846F-45D662A14AABQ28493156-60FADBBD-C1E5-4043-81B8-C73676D4E576Q33497911-2572F4DA-3CCB-4275-A414-5DF4CF7085D5Q33641898-074EC1F5-20EF-41EC-83DF-BA78233E3E4EQ33877932-7FE6EA57-8C63-4BB5-8500-6C7F6D671231Q34030902-93515EE9-D0DF-4531-8C06-764A060F31E3Q34142129-C996B788-2980-4BCA-B7D5-2857445008D6Q34390823-5DF45467-1EB2-4321-A77B-35A0A38D3B1CQ34525373-0A911604-4DA8-4947-8B82-E3923AF8DF83Q35066558-6F5CECEA-BB01-444F-84D6-009CD46B6271Q35079518-A9EC5963-9630-410B-865C-47470DB43A0FQ35085177-DF4B0DA1-DD51-45A0-B6E2-006F98BAD82DQ35858106-1251245B-2E35-4973-80C1-0215ED7EC23BQ36013525-522706DF-154A-4BA1-942B-6FE0826CEB80Q36071289-8D7A4860-AEF2-4434-96C0-76FABBA96795Q36444449-45727983-E418-4547-A13C-21AC248A9D09Q36560134-9D2651EC-F85D-43FD-AB85-4D99FF78EFB5Q36707403-EB7F1845-B40A-4FB2-9C64-5660669DC39AQ37062695-AF7FDC3C-AA03-4700-9993-C4D730B777CEQ37131658-209D97A9-5B04-490B-8685-0A00A5C5A6D5Q37265111-EB06E4AC-CCBF-4768-B17A-A6F75A24CAB7Q37323880-AE063124-023F-48CF-A1BA-4A1F4A935A6BQ37344241-6DCF2B2C-AD94-4749-969F-4500D416B10BQ37377897-5B558646-3CF3-4344-A290-80E66C1F01C8Q37417446-7F668A32-025E-4F50-B019-E7DCA6F2D4C6Q37515786-AF76963A-895B-49DC-9EE8-CD13FE0E7A3AQ37708866-BAECB5E1-9B8E-4CDE-9E60-66ABE4CFB4ADQ37899198-043F334E-D15C-4226-89FB-995FA52DE937Q38070916-D51677D5-F1DE-43D7-899D-2295066EE78FQ38269510-4CF5800F-338F-49AD-990E-585F7143CD39Q38560661-54133D65-126A-4318-A4CF-FF27270F6A74Q38768532-89550A74-C8A3-4AFD-BD6D-750CEAA53BE2Q39044923-82E79DB1-F591-46B5-A9D9-8C8E93AD7643Q39147856-EAA120F8-6B5C-4456-B1DC-1479928D87B3Q39202357-587678A4-CA36-4219-87B7-478313DB0A0AQ39207319-4C436E6F-65E6-43EE-97C0-0964B4C68597Q39702433-D0483B4C-4BCD-477A-ADE6-DAEDE402D120Q40179367-9D940A2F-81AC-4E45-B578-98C585D33490Q40236957-00FE68B5-3ECE-4F98-98E8-4FE1A010A808Q40267702-83FCB833-AF70-452A-B422-14F2CE0EABB7
P2860
Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Evolution, incidence, and susc ...... ne marrow transplant patients.
@en
Evolution, incidence, and susc ...... ne marrow transplant patients.
@nl
type
label
Evolution, incidence, and susc ...... ne marrow transplant patients.
@en
Evolution, incidence, and susc ...... ne marrow transplant patients.
@nl
prefLabel
Evolution, incidence, and susc ...... ne marrow transplant patients.
@en
Evolution, incidence, and susc ...... ne marrow transplant patients.
@nl
P2093
P2860
P356
P1476
Evolution, incidence, and susc ...... ne marrow transplant patients.
@en
P2093
P2860
P304
P356
10.1086/322604
P407
P577
2001-09-05T00:00:00Z